---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-197362"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2022-07-20T23:59:59+00:00"
generated_at: "2026-06-24T10:58:35.238219+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q2 2022: Adj. EPS $8.04, revenue +15.6% to $38.5B; raises FY outlook

## Summary
- GAAP EPS $6.79; adjusted EPS $8.04, up 14.4% YoY.
- Operating revenue $38.5B, up 15.6% YoY; operating gain $2.4B, up 13.7%.
- Medical enrollment grew 2.7M members YoY to 47.1M; up 276K in quarter.
- Full-year adjusted EPS guidance raised to >$28.70, from prior >$28.25.
- Q3 dividend of $1.28/share declared; repurchased 1.3M shares for $624M.

## SEC filing metadata
- accession: 0001193125-22-197362
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2022-07-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312522197362/0001193125-22-197362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312522197362/d383286d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-197362
- JSON: https://secwatch.observer/filing/0001193125-22-197362.json
- Plain text: https://secwatch.observer/filing/0001193125-22-197362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.